Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Other Non-Current Assets: 2010-2022

Historic Other Non-Current Assets for Catalyst Pharmaceuticals (CPRX) over the last 10 years, with Dec 2022 value amounting to $9,000.

  • Catalyst Pharmaceuticals' Other Non-Current Assets changed negligibly% to $9,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $9,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $9,000 for FY2022, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Catalyst Pharmaceuticals reported Other Non-Current Assets of $9,000 as of Q4 2022, which was down 0.00% from $9,000 recorded in Q3 2022.
  • In the past 5 years, Catalyst Pharmaceuticals' Other Non-Current Assets registered a high of $9,000 during Q4 2020, and its lowest value of $8,888 during Q1 2018.
  • Its 3-year average for Other Non-Current Assets is $8,972, with a median of $9,000 in 2022.
  • Data for Catalyst Pharmaceuticals' Other Non-Current Assets shows a peak YoY grew of 1.26% (in 2020) over the last 5 years.
  • Quarterly analysis of 5 years shows Catalyst Pharmaceuticals' Other Non-Current Assets stood at $8,888 in 2018, then remained steady at $8,888 in 2019, then increased by 1.26% to $9,000 in 2020, then remained steady at $9,000 in 2021, then remained steady at $9,000 in 2022.
  • Its Other Non-Current Assets was $9,000 in Q4 2022, compared to $9,000 in Q3 2022 and $9,000 in Q2 2022.